Bioiberica names Luis Solera new CEO
- On April 1 2017, Luis Solera will assume the position of CEO of Bioiberica
- In his career to date, Luis Solera has held various management positions in the Netherlands, Portugal and Spain
On April 1 2017, Luis Solera will assume the position of CEO of Bioiberica. In his career to date, Luis Solera has held various management positions in the Netherlands, Portugal and Spain. Most recently, he was General Manager of a leading family business in the oils and fats sector. Luis Solera is 47 years old and lives in Barcelona with his wife and two children.
Kurt Stoffel, President of Bioiberica, underlined towards the Bioiberica team and its business partners when the event was announced: “We are convinced that as CEO of Bioiberica, Luis Solera will play a decisive role in shaping the future of Bioiberica and boosting the success of our company, aided by our experienced team and our consolidated market position.”
Bioiberica is a biotechnology company specialising in the identification and extraction of biomolecules of high biological and therapeutic value from tissues of animal origin. It is the leading Western producer of heparin (the world's most commonly used anticoagulant and antithrombotic) and leader in osteoarthritis and joint health for people and animals. Bioiberica is also specialist in the development and production of high-quality ingredients for farm animal feed and natural products to beat plant stress.
Related News
On a planet where natural resources are limited and there is increasing concern for the environment, the circular economy has emerged as an innovative and sustainable solution.
We participated in CPHI 2023 in Barcelona, where we showcased our leadership in scientific research, sustainable development and strategic partnerships for a more resilient future with our portfolio of Active Pharmaceutical and Nutraceutical Ingredients.